SEARCH

SEARCH BY CITATION

References

  • BARD, J.A., ZGOMBICK, J., ADHAM, N., VAYSSE, P., BRANCHEK, T.A. & WEINSHANK, R.L. (1993). Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. J. Biol. Chem., 268, 2342223426.
  • BOYLAND, P.S., EASTWOOD, S., ELLIS, C., BERGSMA, D., JONES, B.J., GLOGER, I.S., UPTON, N. & MIDDLEMISS, D.N. (1996). High specific activity [3H]-5-CT binding: correlation of guinea-pig cortex with human cloned 5-HT7 receptors. Br. J. Pharmacol., 117, 132P.
  • BRANCHEK, T.A., GUSTAFSON, E.L., DURKIN, M.M., BARD, J.A. & WEINSHANK, R.L. (1994). Autoradiographic localisation of 5-HT7 and its mRNA in rat CNS by radioligand binding and in situ hybridization histochemistry. Br. J. Pharmacol., 112, (Proc. Suppl.) 100P
  • BROWN, E.A., GRIFFITHS, R., HARVEY, C.A. & OWEN, D.A.A. (1986). Pharmacological studies with SK&F 93944 (temelastine), a novel histamine H1-receptor antagonist with negligible ability to penetrate the central nervous system. Br. J. Pharmacol., 87, 569578.
  • CHENG, Y. & PRUSOFF, W.H. (1973). Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol., 22, 30993108.
  • CLEMETT, D.A., KENDALL, D.A., COCKETT, M.I., MARSDEN, C.A. & FONE, K.C.F. (1999). Pindolol-insensitive [3H]-5-hydroxytryptamine binding in the rat hypopthalamus; identity with 5-hydroxytryptamine7 receptors. Br. J. Pharmacol., 127, 236242.
  • CROWDER, M.J. & HAND, D.J. (1996). Analysis of repeated measures. London: Chapman and Hall.
  • EGLEN, R.M., JASPER, J.R., CHANG, D.J. & MARTIN, G.R. (1997). The 5-HT7 receptor: orphan found. TiPS, 18, 104107.
  • FORBES, I.T., DABBS, S., DUCKWORTH, D.M., JENNINGS, A.J., KING, F.D., LOVELL, P.J., COLLIN, L., BROWN, A.M., HAGAN, J.J., MIDDLEMISS, D.N., RILEY, G.J., THOMAS, D.R. & UPTON, N. (1998). (R)-3,N-Dimethyl-N-[1-methyl-3-(4-methylpiperidin-1-yl)propyl]benzene sulfonamide: The First Selective 5-HT7 Receptor Antagonist. J. Med. Chem., 41, 655657.
  • GELERNTER, J., RAO, P.A., PAULS, D.L., HAMBLIN, M.W., SIBLEY, D.R. & KIDD, K.K. (1995). Assignment of the 5-HT7 receptor gene (HTR7) to chromosome 10q and exclusion of genetic linkage with Tourette syndrome. Genomics, 26, 207209.
  • GRIFFITHS, R.G., LEWIS, A. & JEFFREY, P. (1996). Models of drug absorption in situ and in conscious animals. In Models for Assessing Drug Absorption and Metabolism. eds. Borchardt, RT et al. New York: Plenum Press.
  • GUSTAFSON, E.L., DURKIN, M.A., BARD, J.A., ZGOMBICK, J. & BRANCHEK, T.A. (1996). A receptor autoradiographic and in situ hybridization analysis of the distribution of the 5-ht7 receptor in rat brain. Br. J. Pharmacology, 117, 657666.
  • HAGAN, J.J., LESLIE, R.A., PATEL, S., EVANS, M.L., WATTAM, T.A., HOLMES, S., BENHAM, C.D., TAYLOR, S.G., ROUTLEDGE, C., HEMMATI, P., MUNTON, R.P., ASHMEADE, T.E., SHAH, A.S., HATCHER, J.P., HATCHER, P.D., JONES, D.N.C., SMITH, M.I., PIPER, D.C., HUNTER, A.J., PORTER, R.A. & UPTON, N. (1999). Orexin-A Activates Locus Coeruleus Cell Firing and Increases Arousal in the Rat. Proc. Natl. Acad. Sci., 96, 1091110916.
  • HAGAN, J.J., SLADE, P.D., HATCHER, J., GASTER, L. & JEFFREY, P. (1997). 5-HT1B (formerly 5-HT1Dβ) receptors mediate the hypothermia induced by the 5-HT1B/D agonist SKF 99101H in the Guinea-Pig. Eur. J. Pharmacol., 331, 169174.
  • HEIDMANN, D.E.A., METCALF, M.A., KOHEN, R. & HAMBLIN, M.W. (1997). Four 5-Hydroxytryptamine7 (5HT7) receptor isoforms in human and rat produced by alternative splicing: Species differences due to altered intron-exon organisation. J. Neurochem., 68, 13721381.
  • HOYER, D., CLARKE, D.E., FOZARD, J.R., HARTIG, P.R., MARTIN, G.R., MYLECHARANE, E.J., SAXENA, F.R. & HUMPHREY, P.P.A. (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev., 46, 157243.
  • KIKUCHI, C., NAGASO, H., HIRANU, A.T. & KOYAMA, M. (1999). Tetrahydrobenzindoles: Selective antagonists of the 5-HT7 receptor. J. Med. Chem., 42, 533535.
  • LAWRENCE, A.J. & MARSDEN, C.A. (1992). Terminal autoreceptor control of 5-hydroxytryptamine release as measured by in vivo microdialysis in the conscious guinea-pig. J. Neurochem, 58, 142146.
  • LE BON, O., STANER, L., MURPHY, J.R., HOFFMAN, G., PULL, C.H. & PELC, I. (1997). Critical analysis of the theories advanced to explain short REM latencies and other sleep anomalies in several psychiatric conditions. J. Psychiat. Res., 31, 433450.
  • LIVAK, K.J. (1999). Allelic discrimination using fluorogenic probes and the 5′-nuclease assay. Gen Anal. Biomol. Engin., 14, 143149.
  • LOVELL, P.J., BROMIDGE, S.M., DABBS, S., DUCKWORTH, D.M., FORBES, I.T., JENNINGS, A.J., KING, F.D., MIDDLEMISS, D.N., RAHMAN, S.K., SAUNDERS, D.V., COLLIN, L.L., HAGAN, J.J., RILEY, G.J. & THOMAS, D.R. (2000). A Novel, Potent and Selective 5-HT7 Antagonist: (R)-3-(2-(2-(4-Methyl-piperidin-1-yl)ethyl)-pyrrolidine-1-sulfonyl)-phenol (SB-269970). J. Med. Chem., 43, 342345.
  • LOVENBERG, T.W., BARON, B., DE LECEA, L., MILLER, J.D., PROSSER, R.A., REA, M.A., FOYE, P.E., RACKE, M., SLONE, A.L., SIEGEL, B.W., DANIELSON, P.E., SUTCLIFFE, J.G. & ERLANDER, M.G., (1993). A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythyms. Neuron, 11, 449458.
  • MEUSER, T. & PIERCE, P.A. (1997). 5-Hydroxytryptamine-7 (5-HT7) receptor distribution in dorsal root ganglion. Anaesthesiology, 87, A816.
  • PASTEL, R.H. & FERNSTROM, J.D. (1987). Short-term effects of fluoxetine and trifluoromethylphenylpiperazine on electroencephalographic sleep in the rat. Brain Res., 436, 92102.
  • PLASSAT, J., AMLAIKY, N. & HEN, R. (1993). Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. Mol. Pharmacol., 44, 229236.
  • ROTH, B.L., CRAIGO, S.C., CHOUDHARY, M.S., ULUER, A., MONSMA, F.J.JR., SHEN, Y., MELTZER, H.Y. & SIBLEY, D.R. (1994). Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J. Pharm. Exp. Ther., 268, 14031410.
  • RUAT, M., TRAIFFORT, E., LEURS, R., TARDIVEL-LACOMBE, J., DIAZ, J., ARRANG, J.-M. & SCWARTZ, J.-C., (1993). Molecular cloning, characterisation, and localisation of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc. Natl. Acad. Sci., 90, 85478551.
  • SALOMON, Y. (1979). Adenylate cyclase assay. Adv. Cyclic Nuc. Res., 10, 3555.
  • SCHOEFFTER, P., ULLMER, C., BOBIRNAC, I., GABBIANI, G. & LUBBERT, H. (1996). Functional, endogenously expressed 5-hydroxytryptamine 5-ht7 receptors in human vascular smooth muscle cells. Br. J. Pharmacol., 117, 993994.
  • SHEN, Y., MONSMA, F.J., METCALF, M.A., JOSE, P.A., HAMBLIN, M.W. & SIBLEY, D.R. (1993). Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J. Biol. Chem., 268, 1820018204.
  • SKINGLE, M., HIGGINS, G.A. & FENIUK, W. (1994). Stimulation of central 5-HT1D receptors causes hypothermia in the guinea-pig. J. Psychopharm, 8, 1421.
  • SLEIGHT, A.J., CAROLO, C., PETIT, N., ZWINGELSTEIN, C. & BOURSON, A. (1995). Identification of 5-HT7 receptor binding sites in rat hypothalamus. Mol. Pharmacol., 47, 99103.
  • STAM, N.J., ROESINK, C., DIJCKS, F., GARRITSEN, A., VAN HERPEN, A. & OLIJVE, W. (1997). Human serotonin 5-HT7 receptor: cloning and pharmacological characterisation of two receptor variants. FEBS Letts., 413, 489494.
  • STANER, L., LUTHRINGER, R. & MARCHER, J.-P. (1999). Effects of antidepressant drugs on sleep EEG in patients with major depression. CNS Drugs, 11, 4960.
  • TERON, J.A. (1998). Involvement of the 5-HT7 receptor in craniovascular vasodilatation: Potential in migraine. Proc. West. Pharmacol. Soc., 41, 247251.
  • THOMAS, D.R., GITTINS, S.A., COLLIN, L.L., MIDDLEMISS, D.N., RILEY, G., HAGAN, J., GLOGER, I., ELLIS, C.E., FORBES, I.T. & BROWN, A.M. (1998). Functional characterisation of the human cloned 5-HT7 receptor (long form); antagonist profile of SB-258719. Br. J. Pharmacol., 124, 13001306.
  • THOMAS, D.R., MIDDLEMISS, D.N., TAYLOR, S.G., NELSON, P. & BROWN, A.M. (1999). 5-CT stimulation of adenylyl cyclase activity in guinea pig hippocampus: evidence for involvement of 5-HT7 and 5-HT1A receptors. (1999). Br. J. Pharmacol., 128, 158164.
  • TO, Z.P., BONHAUS, D.W., EGLEN, R.M. & JAKEMAN, L.B. (1995). Characterisation and distribution of putative 5-ht7 receptors in guinea-pig brain. Br. J. Pharmacol., 115, 107116.
  • TSOU, A.P., KOSAKA, A., BACH, C., ZUPPAN, P., YEE, C., TOM, L., ALVAREZ, R., RAMSEY, S., BONHAUS, D.W., STEFANICH, E., JAKEMAN, L., EGLEN, R.M. & CHAN, H.W. (1994). Cloning and expression of a 5-hydroxytryptamine7 receptor positively coupled to adenyly cyclase. J. Neurochem., 63, 456464.
  • YING, S.W. & RUSAK, B. (1997). 5-HT7 receptors mediate serotonergic effects on light-sensitive suprachiasmatic nucleus neurons. Brain Res., 755, 246254.